UTMD
Utah Medical Products, Inc. (UTMD) ESG Analysis Analysis (2026)
Environmental
UTMD’s low leverage and limited capital intensity reduce environmental transition exposure versus more asset-heavy medtech peers, but this is an indirect advantage rather than a direct sustainability leader.
The company’s modest R&D-to-revenue ratio suggests a comparatively restrained innovation footprint, which can lower resource demand versus peers with heavier development spending.
No provided evidence indicates material emissions, waste, or energy-management disclosure strength, leaving UTMD broadly in line with smaller device peers rather than clearly advantaged.
As a medical-device manufacturer, UTMD faces regulated materials and product-stewardship expectations, but its small scale likely limits absolute environmental burden versus larger diversified peers.
Social
UTMD’s medical-device focus supports a structurally favorable social profile because product safety and patient outcomes are core operating requirements, similar to stronger peers.
Low stock-based compensation relative to revenue suggests less dilution-driven employee friction than peers with heavier equity compensation, supporting workforce alignment.
The company’s small scale can improve accountability and responsiveness to quality issues, although it also limits the breadth of formal social-program disclosure versus larger peers.
No provided data indicates elevated labor, safety, or community controversies, so UTMD appears socially stable relative to peers with more visible operational footprints.
Governance
UTMD’s extremely low debt-to-equity ratio indicates conservative balance-sheet governance, which reduces creditor pressure and financial-risk spillovers versus more leveraged peers.
Net debt to EBITDA is near zero, suggesting disciplined capital structure management and lower refinancing risk than peers that rely more heavily on debt.
Low stock-based compensation relative to revenue points to restrained executive and employee equity dilution, which is generally more shareholder-aligned than peer averages.
The absence of provided controversy signals and the company’s conservative capital allocation support a cleaner governance profile, though disclosure depth may still trail larger listed peers.
Overall Score
UTMD screens as a strong relative ESG name because conservative governance and stable social fundamentals outweigh a merely moderate environmental profile versus peers.
Score Driver: Conservative Governance, Especially Minimal Leverage And Low Dilution, Is The Clearest Relative ESG Advantage.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Utah Medical Products, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

